As more biotech companies implement agile frameworks such as scrum, they are adapting the practices to work in their highly regulated scientific environment. Oliver Wueseke shares his experience implementing scrum and other agile practices at two biotech startups. He will highlight the benefits and challenges he has seen, and why he believes that agile work models will become the standard in the biotech industry.